Literature DB >> 27042473

Natural Killer Cell Lymphoma: A Case with Classification Dilemma.

Ankit Kumar Jitani1, Yookarin Khonglah2, Ritesh Kumar3, Bidyut Bikash Gogoi4, Ekta Jajodia4.   

Abstract

Non-Hodgkins lymphoma of the Natural Killer (NK) cell type is rare. World Health Organisation recognises 3 NK-cell phenotypic entities; extranodal NK/T cell lymphoma, nasal type (ENK/TL); aggressive NK cell leukaemia (ANKL); and chronic lymphoproliferative disorders of NK cells (CLPD-NK) which is classified as a provisional entity. Though specific clinical, morphological and immunophenotypic criteria have been laid down to diagnose these conditions there may however, be considerable variations in the clinical presentation making diagnosis difficult. We present a case with contrasting clinical and haematopathological findings posing difficulty in its diagnosis and classification, and despite the aggressive presentation showing favourable response to treatment.

Entities:  

Keywords:  Flow cytometry; NK-cell; Non-Hodgkins lymphoma

Year:  2016        PMID: 27042473      PMCID: PMC4800538          DOI: 10.7860/JCDR/2016/15501.7177

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  7 in total

1.  Aggressive natural killer cell leukaemia: a rare and fatal disorder.

Authors:  A Gogia; A Kakar; S P Byotra; M Bhargav
Journal:  J Assoc Physicians India       Date:  2010-11

2.  Chronic lymphoproliferative disorder of natural killer cells: a distinct entity with subtypes correlating with normal natural killer cell subsets.

Authors:  W G Morice; D Jevremovic; H Olteanu; A Roden; G Nowakowski; S Kroft; C A Hanson; P J Kurtin
Journal:  Leukemia       Date:  2010-01-28       Impact factor: 11.528

Review 3.  How I treat NK/T-cell lymphomas.

Authors:  Eric Tse; Yok-Lam Kwong
Journal:  Blood       Date:  2013-05-07       Impact factor: 22.113

4.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

Authors:  E A Eisenhauer; P Therasse; J Bogaerts; L H Schwartz; D Sargent; R Ford; J Dancey; S Arbuck; S Gwyther; M Mooney; L Rubinstein; L Shankar; L Dodd; R Kaplan; D Lacombe; J Verweij
Journal:  Eur J Cancer       Date:  2009-01       Impact factor: 9.162

5.  International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.

Authors:  Julie Vose; James Armitage; Dennis Weisenburger
Journal:  J Clin Oncol       Date:  2008-07-14       Impact factor: 44.544

6.  NK-cell lymphomas and leukemias: a spectrum of tumors with variable manifestations and immunophenotype.

Authors:  Robert P Hasserjian; Nancy Lee Harris
Journal:  Am J Clin Pathol       Date:  2007-06       Impact factor: 2.493

Review 7.  Aggressive mature natural killer cell neoplasms: from epidemiology to diagnosis.

Authors:  Margarida Lima
Journal:  Orphanet J Rare Dis       Date:  2013-07-01       Impact factor: 4.123

  7 in total
  1 in total

1.  EBV-negative aggressive NK-cell leukemia/lymphoma: a clinical and pathological study from a single institution.

Authors:  Juehua Gao; Amir Behdad; Peng Ji; Kristy L Wolniak; Olga Frankfurt; Yi-Hua Chen
Journal:  Mod Pathol       Date:  2017-05-26       Impact factor: 7.842

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.